Sioux Technologies co-led SamanTree’s series A round, which will support marketing of the EPFL spinout’s subcellular resolution microscopy scanner for surgical cancer interventions.
SamanTree Medical, a Switzerland-based cancer tissue mapping technology spinout from École polytechnique fédérale de Lausanne (EPFL), closed a Sfr9.5m ($9.3m) series A round on Monday co-led by venture capital firm Panakès Partners.
Sioux Tech Fund, an investment vehicle of technology development services provider Sioux Technologies, co-led the round, which also included Bom Brabant Ventures, the VC arm of Dutch state-owned regional development agency Brabantse Ontwikkelings Maatschappij, as well as Btov Partners and a range of unnamed, existing investors.
Founded in 2014, SamanTree is commercialising a digital microscopy scanner dubbed Histolog that provides images of biological tissue at subcellular resolution to support the surgical removal of tumours from the body without damaging healthy tissue.
SamanTree will utilise the series A funding to market Histolog to potential customers. Fabrizio Landi, managing partner at Panakès Partners, will join the board of directors.
SamanTree Medical’s chief technology officer is Etienne…
